Listed

Tempest Therapeutics, Inc.

TPSTNasdaqCIK 1544227HealthcareFiscal year ends Dec 31

Reports and events: 308 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Tempest Therapeutics, Inc., Reports and events
FiledFormWhat it isAccession number
2012-12-0716:37 ET8-K5.02 Departure or appointment of officers or directors0001104659-12-082742
2012-11-1320:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-12-077343
2012-11-1318:25 ET10-QQuarterly reportPeriod 2012-09-300001104659-12-077250
2012-11-0913:42 ET8-K8.01 Other events0001104659-12-076307
2012-10-3020:33 ET8-K5.02 Departure or appointment of officers or directors0001104659-12-072305
2012-08-2922:25 ETS-1Registration statement0001047469-12-008575
2012-08-1417:36 ET10-QQuarterly reportPeriod 2012-06-300001104659-12-057721
2012-08-1412:56 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001104659-12-057589

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 15, 2026, 00:20 ET. Listed shows no prices and gives no investment advice.